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Summary – A patent foramen ovale has been reported to be more frequently detected in cryptogenic stroke, with paradoxical emboli-
sm as the major pathogenetic mechanism. The standard procedure for the detection of a patent foramen ovale is transesophageal echo-
cardiography. Transcranial Doppler sonography with bubble test is almost as reliable as transesophageal echocardiography. Seventeen   
patients with acute ischemic stroke and transient ischemic attacks hospitalized at  the Department  of Neurology in Novi Sad un-
derwent examinations to detect a patent foramen ovale, which  was found in 55.6% of patients with cryptogenic stroke. The average 
age of these patients was 30.6 years. Transcranial Doppler sonography showed 100% sensitivity and 100% specificity for the predicti-
on of right-to-left shunts proven by transesophageal contrast echocardiography. Both positive and negative predictive values in our 
group of patients were 1. Transcranial Doppler with bubble test is a reliable method for the detection of a patent foramen ovale, with a 
high level of sensitivity and specificity which is comparable with transesophageal echocardiography. Moreover, it is cheaper and more 
comfortable than transesophageal echocardiography, and should be used routinely in neurological practice.
Key words: Embolism, Paradoxical; Foramen Ovale; Heart Septal Defects; Echocardiography, Transesophageal; Ultrasonography, 
Doppler, Transcranial; Microbubbles; Stroke
Corresponding Author: Dr Željko Živanović, Klinika za neurologiju, 
21000 Novi Sad, Hajduk Veljkova 1-7, E-mail:drzzivanovic@yahoo.com
Introduction
The patent foramen ovale (PFO) is the most com-
mon abnormality of fetal origin [1,2]. Several studies 
have shown a significant correlation between cryp-
togenic stroke (stroke of undetermined etiology) and 
the presence of a PFO, suggesting that paradoxical 
embolism crossing from the venous to arterial circu-
lation through a PFO  may be an important cause of 
stroke, especially in the young [1-3]. PFO is a com-
mon and benign finding present on autopsy in ap-
proximately 25% of general population [4], and in up 
to 40% of patients with cryptogenic stroke [5].
The real causative relationship between the pres-
ence of PFO and stroke remains unclear, even though 
the presence of PFO is associated with an increased 
risk of ischemic stroke [1,6-8]. The presumptive di-
agnosis of paradoxical emboli is based on the fol-
lowing criteria: embolic stroke in the absence of left-
sided  cardiac  or  proximal  arterial  source,  venous 
thromboembolism (deep venous thrombosis or pul-
monary  embolism),  and  intracardiac  defect  with 
right-to-left shunting [9]. The verification of PFO in 
patients with ischemic stroke is important not only 
for the clarification of mechanism of stroke, but also 
for the therapeutic approach [10,11]. 
Transoesophageal  echocardiography  (TEE)  is  a 
gold standrad and the most sensitive diagnostic test 
for the detection of atrial septal defects [12,13]. Trans- 
thoracic  echocardiography  (TTE)  and  transcranial 
Doppler (TCD) ultrasonography are also reliable al-
ternatives to TEE in diagnosing PFO, and have shown 
the  increased  sensitivity  and  specificity  compared 
with TEE for the detection of PFO [13-15]. 
The primary end-point of this study was to estab-
lish the correlation between the presence of PFO and 
cryptogenic stroke. The secondary end-point was to 
examine the accuracy of transcranial Doppler for the 
detection of right-to-left shunt (RLS).  We tried to 
determine the sensitivity and specificity of TCD in 
comparison to TEE, and justify the role of TCD as a 
diagnostic tool in cryptogenic stroke. 
Material  and Methods
Thirteen patients (7 men and 6 women) were in-
cluded in the study in the period from December 
2008 to September 2009. The patients suffered eith- 
er stroke or transient ischemic attack (TIA). All su-
bjects  underwent  both  TCD  bubble  study  (perfor-
med with Sonara Version 04, VIASIS) at the Depar-
tment of Neurology of Clinical Center of Vojvodina 
and TEE, which was performed by the experienced 
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cular Diseases, Sremska Kamenica. Only final cardi-
ologic findings were taken into account.
Contrast transcranial Doppler ultrasound - 
Bubble study 
In order to monitor the blood flow and detect the 
TCD embolus detection the middle cerebral artery 
(MCA) is insonated bilaterally through the temporal 
bone windows. The detection of microemboli is ba- 
sed on the measurement of the backscatter from the 
emboli and the backscatter from the normal blood 
flow [16]. The difference between these backscatters 
(embolus-to-blood  ratio)  enables  emboli  detection 
[17]. 
TCD is performed at the bedside in supine posi-
tion. The first step is to place the  head-frame, which 
is used to prevent  the ultrasound probe from moving 
and  related  artifacts.  Two  2-MHz  transducers  are 
mounted on the temporal planes (Figure 1). After the 
examiner finds a high  quality Doppler signal  (Fig-
ure 2), the ultrasound probe can be secured by a bolt. 
Two main contrast agents can be used: agitated sa-
line containing tiny air bubbles and a galactose-based 
agent (Echovist-300, Schering AG) [18]. We used the 
former. An 18 or 20 – gauge needle connected by a 
3-way stopcock is cannulated into the right cubital vein 
[19]. Microcavitation saline contrast is generated by a 
three-way  stopcock  connected  to  a  10-ml  syringe  I 
containing 9 ml of 0.9% saline and to a syringe II con-
taining 1 ml of air aspirated through a bacterial filter, 
and then applied to the patient (Figure 3). One ml air 
(syringe I) and 9 ml saline (syringe II) should be rapid-
ly and energetically exchanged between the syringes at 
least ten times. Once the contrast is prepared, 10 ml is 
immediately injected as a bolus into the right cubital 
vein [20]. The injected contrast reaches the right atrium 
through the veins, and if PFO is present, the contrast 
will pass into the left atrium and then into the  systemic 
or brain circulation. Passing through ACM microbub-
bles (MB) makes typical auditory and visual embolic 
signals (ES), usually 10-15 seconds after the injection 
(Figure 4).
 Abbreviations
 PFO  – Patent Foramen Ovale
 TEE  – Transoesophageal Echocardiography
 TTE  – Transthoracic Echocardiography
 TCD  – Transcranial Doppler 
 RLS  – Right-to-Left Shunt
 MCA  – Middle Cerebral Artery
 MB  – Microbubbles
 ES  – Embolic Signals
 VM  – Valsalva Maneuver
 CT  – computed tomography
 MRI  – magnetic resonance imaging
 TIA  – Transient Ischemic Attacks
 ASA  – atrial septal aneurysm 
Fig. 1. Headframe used to secure ultrasound probes 
Slika 1. Ram (šlem) za fiksiranje ultrazvučnih sondi
Fig 2. Bilateral monitoring of both MCA 
Slika 2. Bilateralni monitornig obe MCA
Fig 3. Agitated saline injection using 3-way stopcock tube 
Slika 3. Aplikacija uzburkanog fiziološkog rastvora pomoću si-
stema sa trokrakom slavinom
Fig 4. Occurrence of  ES in ACM 
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If bubble test is negative, it should be repeated with 
Valsalva maneuver (VM) which increases the sensitiv-
ity [21]. In case of detection of massive ES without a 
VM (’curtain pattern’), one should not perform a VM 
to prevent possible air embolism. VM should be started 
5s after the beginning of the contrast agent injection 
and should be maintained for at least 5s [22].   
Results
We performed the TCD bubble study in 13 patients 
(man to woman ratio 1.17:1). The average age was 31.4 
years, ranging from 17 to 43 years. All the patients had 
suffered cerebral ischemic events, nine with proven (by 
computed tomography - CT or magnetic resonance im-
aging - MRI) ischemic stroke, and four with TIA.
PFO was found in seven patients (53.8%), five with 
stroke and two with TIA. The average age of patients 
with PFO was 28.4 years. Out of nine patients with 
cryptogenic  stroke,  five  were  found  to  have  PFO 
(55.6%).  The  average  age  of  these  patients  was  30.6 
years while the average age of patients with stroke and 
without PFO was 38.5 years. 
TTE and TEE were performed in ten patients to de-
tect or rule out intracardiac shunt. The sensitivity and 
specificity of TCD were compared with TEE. Our study 
demonstrates  that  contrast  TCD  detects  TEE-proven 
R L S ,  b o t h  t h e   s e n s i t i v i t y  a n d  t h e  s p e c i f i c i t y  b e i n g  
100%. Both positive and negative predictive values in 
our group of patients were 1. The sensitivity of TTE was 
57.2% and the specificity was 66.7%. The positive pre-
dictive value was 0.8 and the negative one was 0.4.
None of the five patients with stroke and PFO was 
verified to have deep venous thrombosis as a possible 
source of embolism.
Discussion
Although the presence of PFO is associated with 
the increased risk of ischemic stroke, the causative 
relationship between PFO and stroke is unclear. The 
true existence of this relationship has been  widely 
debated  [23].  The  convincing  association  between 
PFO and stroke has been recently reported by sever-
al investigators, predominantly amongst younger pa-
tients with cryptogenic stroke [1,24,25]. In patients 
with cryptogenic stroke, approximately one third of 
diagnosed PFOs seems to be incidental, and hence 
endovascular closure is not likely to reduce their re-
current stroke risk. This probability is related to pa-
tients’  characteristics  such  as  age,  morphological 
features of PFO and the presence of a concurrent 
atrial septal aneurysm (ASA) [26].
The percentage of patients with PFO among stroke 
cases in our study was 55.6%. In a large prospective 
multicenter study PFO - ASA study of the 581 stroke 
patients, 267 (45.9%) had PFO [27]. A recent meta-
analysis of 23 case – control studies showed that in 
age-inclusive studies, the proportion of patients with 
PFO  among  cryptogenic  stroke  cases  ranged  from 
12% to 78% (the median being 40%), and the corre-
sponding proportion among the control subjects with 
ischemic stroke of a known cause ranged from 6% to 
33% (the median being 20%). In the studies on young-
er patients, the proportion of patients with PFO ranged 
from 29% to 73% (the median being 56%) among the 
stroke patients and 0% to 33% (the median being 14%) 
among the controls [26]. 
The  striking  finding  of  our  study  is  that  the   
stroke patients with PFO were younger than patients 
without PFO. The average age of our stroke patients 
with PFO was 30.6 years. In PFO – ASA study the 
average age of patients with cryptogenic stroke and 
PFO was 40.1 years versus 44.5 years in non- PFO 
patients  [27].  In  the  Patent  Foramen  Ovale  Cryp-
togenic Stroke Study (PICSS), which included 630 
stroke patients, the average age of patients with PFO 
was 57.9 years versus 59.6 in non- PFO [10]. This 
discrepancy between our and other studies could be 
explained by the selection of our patients. 
TCD  accuracy  in  the  diagnosis  of  PFO  ranges 
from 68% to 100% in the literature data [15,18,28-30]. 
Our  study  demonstrates  that  contrast  TCD  detects 
TEE-proven RLS with the  sensitivity of 100% and 
the specificity of 100%. TTE in combination with an 
agitated saline injection has a similar sensitivity and 
specificity as TCD taking TEE as the gold standard 
for the detection of right-to-left shunts [13,31]. In our 
study TTE did not show a high level of accuracy. 
The specificity to diagnose RLS at the atrial level 
may be increased by using defined times of ES ap-
pearance regarded as the evidence for MB crossing at 
the atrial level. The general agreement for a cut off 
interval does not exist, and therefore a wide range of 
six heartbeats is used. The passage time from the cu-
bital injection site to the MCA through intracardiac 
shunt is about 11 seconds and about 14 seconds for 
the passage from the cubital injection site to the MCA 
in case of the  pulmonary passage [32]. Therefore, the 
overlap interval for the intrapulmonary and atrial lev-
el passage must be assumed. Moreover, the precise 
time window is difficult to define because the time 
window cannot differentiate between RLS at the atri-
al level and RLS at different sites of the vascular sys-
tem. Clinical relevance of the MB test can be achieved 
by the quantitative analysis [20]. 
Recent studies have emphasized the need to quantify 
the size of cardiac RLS using TEE [33]. The assessment 
of the RLS size can be achieved by TCD in a semi-
quantitative manner by counting ES after injection [34-
36]. A four-level categorization was accepted at the  In-
ternational Consensus Meeting according to MB ap-
pearance in the TCD spectrum using unilateral MCA 
monitoring (values for bilateral monitoring in parenthe-
ses): 1. no occurrence of ES; 2. 1–20 ES; 3. >20 ES, but 
no curtain, and 4. curtain, where a single ES cannot be 
discriminated within the TCD spectra [20].
None of our patients showed clinical and ultra-
sound  (duplex  scanner)  evidence  of  deep  venous 
thrombosis of the legs, which is in line with the lit-
erature  data.  Deep  venous  thrombosis  is  detected 
only in a small number of patients with suspected 
paradoxical embolism [37,38].
The small size and ephemeral integrity of micro-
bubbles  make  this  method  safe,  practically  com-
pletely free of risk. Only one case related to cerebral 
ischemic  event  as  a  complication  of  TCD  bubble 
study has been reported in The United States [39].Živanović Ž, i sar. Transkranijalni dopler u detekciji PFO 448
Conclusion
The  association  between  patent  foramen  ovale 
and risk of recurrent stroke in young patients with 
cryptogenic  stroke  is  not  just  a  matter  of  coinci-
dence.  The  optimal  diagnosis  of  patent  foramen 
ovale and treatment to prevent a recurrent stroke are of 
extreme clinical importance for this subgroup of stroke 
patients. 
Transoesophageal echocardiography is still the gold 
standard in detecting patent foramen ovale, but contrast-
enhanced transcranial Doppler must be regarded a rea-
sonable alternative. Transcranial Doppler is a reliable and 
cheap method for patent foramen ovale detection and a 
negative  contrast-enhanced  transcranial  Doppler  may 
avoid the need for a transoesophageal echocardiography 
for the diagnosis of patent foramen ovale. Furthermore, 
transcranial Doppler has turned out to be a highly sensi-
tive and specific method to study the functional impact of 
cardiac right-to-left shunt and other right-to-left shunt. 
The main advantages of contrast transcranial Doppler 
in comparison to transoesophageal echocardiography in 
the detection of right-to-left shunt are: transcranial Dop-
pler is more comfortable than transoesophageal echocar-
diography, size and functional relevance of right-to-left 
shunt can be assessed more easily by using transcranial 
Doppler than by using transoesophageal echocardi-
ography;  transcranial  Doppler  can  detect  not  only 
cardiac but also extracardiac right-to-left shunt.
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Uvod
Perzistentni foramen ovale je jedna od najčešćih anomalija fetalnog 
razvoja. Mnoge studije su pokazale signifikantnu povezanost izme-
đu kriptogenog moždanog udara i perzistentnog foramena ovale, 
sugerišući paradoksalnu embolizaciju kao najverovatniji patofizio-
loški mehanizam. Zlatni standard za dijagnostikovanje perzisten-
tnog foramena ovale je transezofagealna ehokardiografija. Tran-
skranijalnim doplerom, uz primenu kontrasta, takođe se može otkri-
ti njegovo prisustvo. U našem istraživanju poredili smo pouzdanost 
ovih dijagnostičkih procedura u detekciji perzistentnog foramena 
ovale.   
Materijal i metode
Ispitivanje je sprovedeno na 13 bolesnika lečenih na Klinici za neu-
rologiju u Novom Sadu zbog akutnog cerebrovaskularnog incidenta 
(9 sa ishemijskim moždanim udarom i 4 sa tranzitornim ishemijskim 
atakom). Test sa mikromehurićima zasnovan je na mogućnosti tran-
skranijalnog doplera, da nakon intravenske aplikacije kontrasta, de-
tektuje  vazdušne  embolijske  signale  u  srednjoj  moždanoj  arteriji. 
Primenjen je protokol sa 10 ml uzburkanog fiziološkog rastvora. 
Senzitivnost i specifičnost transkranijalnog doplera određivana je u 
odnosu na kardiološke nalaze transezofagealne ehokardiografije.
Rezultati
Prosečna starost naših ispitanika bila je 31,4 godina. Perzisten-
tni foramen ovale je detektovan kod 53,8% svih bolesnika, a kod 
55,6% bolesnika sa kriptogenim moždanim udarom. Prosečna 
starost bolesnika sa perzistentnim foramenom ovale i kriptogenim 
moždanim udarom iznosila je 30,6 godina. Transkaranijalni do-
pler je pokazao 100% senzitivnosti i 100% specifičnosti (pozitiv-
na prediktivna vrednost 1, negativna prediktivna vrednost 1). 
Zaključak
Transkranijalni dopler uz test sa mikromehurićima, pokazao se 
kao pouzdana metoda pregleda u detekciji perzistentnog forame-
na ovale. Negativan nalaz isključuje potrebu za ehokardiograf-
skim pregledom sa ciljem njegovog otkrivanja. Prednosti tran-
skranijalnog  doplera  su  jednostavnost  izvođenja,  niža  cena, 
komfornost za bolesnika, a pomoću njega se može otkriti, ne 
samo kardijalni nego i ekstrakardijalni desno-levi šant krvi. 
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